UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
________________________
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of
Report (Date of earliest event reported): April
9, 2007
MEDASORB
TECHNOLOGIES CORPORATION
(Exact
name of registrant as specified in its charter)
|
Nevada
|
|
000-51038
|
|
98-0373793
|
|
(State
or other jurisdiction
of
incorporation)
|
|
(Commission
File
Number)
|
|
(I.R.S.
Employer
Identification
Number)
|
7
Deer
Park Drive, Suite K, Monmouth Junction, New Jersey 08852
(Address
of principal executive office) (Zip Code)
Registrant’s
telephone number, including area code: (732)
329-8885
Check
the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2.below):
o
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule
14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant
to Rule 14d-2(b) under the Exchange Act (17
CFR
240.14d-2(b))
o
Pre-commencement communications pursuant
to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13c-4(c))
| Item
5.02. |
Departure
of Directors or Principal Officers; Election of Directors; Appointment
of
Principal Officers; Compensatory Arrangements of Certain
Officers.
|
Effective
April 9, 2007, Dr. Edward R. Jones, M.D., MBA, was appointed to our Board of
Directors.
Dr.
Jones
is an attending physician at the Albert Einstein Medical Center and Chestnut
Hill Hospital as well as Clinical Professor of Medicine at Temple University
Hospital. Dr. Jones has published or contributed to the publishing of 30
chapters, articles, and abstracts on the subject of treating kidney-related
illnesses. He is a sixteen-year member of the Renal Physicians Association,
the
Philadelphia County Medical Society and a past board member of the National
Kidney Foundation of the Delaware Valley. Dr. Jones has been elected to serve
as
the next President of the Renal Physicians Association starting in
2009.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Date:
April 12, 2007
| |
|
|
| |
MEDASORB
TECHNOLOGIES CORPORATION |
|
|
|
| |
By: |
/s/ David
Lamadrid |
| |
David
Lamadrid,
Chief
Financial Officer
|
| |
|